andirobicin B glucoside
(8S,9R,13R,16R,17R)-17-acetyl-3,16-dihydroxy-4,9,13,14-tetramethyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,8,12,15,16,17-hexahydro-6H-cyclopenta[a]phenanthren-11-one
Also Known As: Andirobicin B glucoside|KST-1A2202|(8S,9R,13R,16R,17R)-17-acetyl-3,16-dihydroxy-4,9,13,14-tetramethyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,8,12,15,16,17-hexahydro-6H-cyclopenta[a]phenanthren-11-one|22,23,24,25,26,27,29-Heptanor-1,2,3,4,5,10-dehydro-2-O-glucopyranosyl-3,16-dihydroxycucurbita-11,20-dione|(9|A,14xi,16|A)-1,16-dihydroxy-9,14-dimethyl-11,20-dioxo-4,9-cyclo-9,10-secopregna-1,3,5(10)-trien-2-yl |A-d-glucopyranoside|19-Norpregna-1,3,5(10)-triene-11,20-dione, 2-(beta-D-glucopyranosyloxy)-3,16-dihydroxy-4,9,14-trimethyl-, (9beta,16alpha)-|(14xi)-1,16alpha-Dihydroxy-9alpha,14-dimethyl-11,20-dioxo-8beta-4,9-cyclo-9,10-secopregna-1,3,5(10)-trien-2-yl beta-D-glucopyranoside|(8S,9R,13R,16R,17R)-17-acetyl-3,16-dihydroxy-4,9,13,14-tetramethyl-2-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-7,8,12,15,16,17-hexahydro-6H-cyclopenta(a)phenanthren-11-one|1,16-Dihydroxy-9,14-dimethyl-11,20-dioxo-4,9-cyclo-9,10-secopregna-1,3,5(10)-trien-2-yl hexopyranoside
| Molecular Formula | C29H40O10 |
|---|---|
| Molecular Weight | 548.26215 g/mol |
| LogP | 1.5 |
| Topological Polar Surface Area | 174.0 Ų |
| Hydrogen Bond Donors | 6 |
| Hydrogen Bond Acceptors | 10 |
| Rotatable Bonds | 4 |
| Exact Mass | 548.26215 |
| Monoisotopic Mass | 548.26215 |
| Heavy Atoms | 39 |
| Complexity | 989.0 |
Chemical Identifiers
| CAS Number | 18357-38-5 |
|---|---|
| SMILES | CC1=C2CC[C@@H]3[C@](C2=CC(=C1O)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)(C(=O)C[C@]5(C3(C[C@H]([C@@H]5C(=O)C)O)C)C)C |
| InChIKey | FKNMUGKCXFULAT-XBFFBVMRSA-N |
Product Overview
andirobicin B glucoside (CAS 18357-38-5), with molecular formula C29H40O10 and molecular weight 548.26215 g/mol. IUPAC: (8S,9R,13R,16R,17R)-17-acetyl-3,16-dihydroxy-4,9,13,14-tetramethyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-7,8,12,15,16,17-hexahydro-6H-cyclopenta[a]phenanthren-11-one.